Adolfo Aleman

1.2k total citations
33 papers, 435 citations indexed

About

Adolfo Aleman is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Adolfo Aleman has authored 33 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 21 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Adolfo Aleman's work include Multiple Myeloma Research and Treatments (23 papers), Protein Degradation and Inhibitors (14 papers) and CAR-T cell therapy research (10 papers). Adolfo Aleman is often cited by papers focused on Multiple Myeloma Research and Treatments (23 papers), Protein Degradation and Inhibitors (14 papers) and CAR-T cell therapy research (10 papers). Adolfo Aleman collaborates with scholars based in United States, United Kingdom and Qatar. Adolfo Aleman's co-authors include Samir Parekh, Sundar Jagannath, Deepu Madduri, Alessandro Laganà, Joshua Brody, Joshua Richter, Oliver Van Oekelen, Bhaskar Upadhyaya, Hearn Jay Cho and Seunghee Kim‐Schulze and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Adolfo Aleman

30 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adolfo Aleman United States 8 235 211 133 81 59 33 435
Jiazhen Cui China 11 312 1.3× 139 0.7× 74 0.6× 79 1.0× 118 2.0× 39 423
Huiwen Jiang China 11 367 1.6× 135 0.6× 122 0.9× 102 1.3× 142 2.4× 27 533
Gurbakhash Kaur United States 8 221 0.9× 135 0.6× 103 0.8× 48 0.6× 101 1.7× 39 350
Ruimin Hong China 9 283 1.2× 127 0.6× 43 0.3× 60 0.7× 75 1.3× 29 355
Kotaro Miyao Japan 11 215 0.9× 91 0.4× 83 0.6× 85 1.0× 90 1.5× 34 377
Satiro De Oliveira United States 12 307 1.3× 255 1.2× 69 0.5× 130 1.6× 178 3.0× 41 573
Katherine D. Cummins United States 8 408 1.7× 281 1.3× 175 1.3× 115 1.4× 123 2.1× 18 595
Shambavi Richard United States 15 394 1.7× 268 1.3× 353 2.7× 48 0.6× 114 1.9× 64 708
Carrie Yuen United States 7 284 1.2× 163 0.8× 77 0.6× 70 0.9× 123 2.1× 19 470
Chunrong Tong China 11 337 1.4× 108 0.5× 104 0.8× 69 0.9× 113 1.9× 50 450

Countries citing papers authored by Adolfo Aleman

Since Specialization
Citations

This map shows the geographic impact of Adolfo Aleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adolfo Aleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adolfo Aleman more than expected).

Fields of papers citing papers by Adolfo Aleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adolfo Aleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adolfo Aleman. The network helps show where Adolfo Aleman may publish in the future.

Co-authorship network of co-authors of Adolfo Aleman

This figure shows the co-authorship network connecting the top 25 collaborators of Adolfo Aleman. A scholar is included among the top collaborators of Adolfo Aleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adolfo Aleman. Adolfo Aleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gleason, Charles, John F. Crary, Lusheng Song, et al.. (2025). Progressive multifocal leukoencephalopathy and BK virus-nephropathy with bispecific antibody therapy in multiple myeloma. Haematologica. 111(1). 431–435. 1 indexed citations
2.
Aleman, Adolfo, Erin Moshier, Adriana Rossi, et al.. (2025). Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy. Clinical Cancer Research. 31(20). 4333–4344. 1 indexed citations
3.
Vesole, David H., et al.. (2024). Restoring sensitivity to daratumumab with all-transretinoic acid in a patient with daratumumab-refractory multiple myeloma: A case report and review of the literature. SHILAP Revista de lepidopterología. 17. 100336–100336. 1 indexed citations
4.
Coffey, David G., Keren Osman, Adolfo Aleman, et al.. (2024). Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. Journal for ImmunoTherapy of Cancer. 12(4). e008110–e008110. 5 indexed citations
5.
Aleman, Adolfo, et al.. (2024). Mortality trends (1999-2022) in patients with multiple myeloma with pneumonia, influenza, and COVID-19.. Journal of Clinical Oncology. 42(16_suppl). 7553–7553. 1 indexed citations
6.
Aleman, Adolfo, et al.. (2024). Improving Anti-BCMA CAR-T Functionality with Novel Celmods in Multiple Myeloma. Blood. 144(Supplement 1). 3259–3259.
7.
Aleman, Adolfo, Rongbao Zhao, Rahul Sanawar, et al.. (2024). BCMA CART Therapy Failure in Myeloma Is Associated with Immunosuppressive S100A8/9 Overexpression and Can be Ameliorated with Novel Monoclonal Antibodies. Blood. 144(Supplement 1). 589–589. 2 indexed citations
8.
9.
Aleman, Adolfo, Bhaskar Upadhyaya, Oliver Van Oekelen, et al.. (2023). P-175 Improving Anti-BCMA CAR-T functionality with novel immunomodulatory agent Iberdomide (CC220) in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 23. S131–S132. 6 indexed citations
10.
Feinman, Rena, Ariel A. Aptekmann, Iriana Colorado, et al.. (2023). Gut Microbiota Diversity and Composition Is Associated with High-Risk Myeloma. Blood. 142(Supplement 1). 3294–3294. 2 indexed citations
11.
Restrepo, Paula, Sherry Bhalla, Yogita Ghodke‐Puranik, et al.. (2022). A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma. JCO Precision Oncology. 6(6). e2200147–e2200147. 14 indexed citations
12.
Thibaud, Santiago, Oliver Van Oekelen, Tarek H. Mouhieddine, et al.. (2022). Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy. Blood. 140(Supplement 1). 614–616. 17 indexed citations
13.
Oekelen, Oliver Van, Adolfo Aleman, Bhaskar Upadhyaya, et al.. (2021). Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature Medicine. 27(12). 2099–2103. 151 indexed citations
14.
Restrepo, Paula, Sherry Bhalla, Adolfo Aleman, et al.. (2021). Transcriptomic Correlates of Response to Selinexor in Multiple Myeloma Reveal a Predictive Signature. Blood. 138(Supplement 1). 457–457. 1 indexed citations
15.
Melnekoff, David T., Yogita Ghodke‐Puranik, Oliver Van Oekelen, et al.. (2021). Single-Cell Profiling Reveals Contribution of Tumor Extrinsic and Intrinsic Factors to BCMA-Targeted CAR-T Cell Efficacy in Multiple Myeloma. Blood. 138(Supplement 1). 326–326. 7 indexed citations
16.
Oekelen, Oliver Van, Tarek H. Mouhieddine, Megan Metzger, et al.. (2021). Clinical Outcomes and Treatment Strategies for Relapsed/Refractory Myeloma Patients after Relapse on BCMA-Targeted CAR T. Blood. 138(Supplement 1). 2704–2704. 7 indexed citations
17.
Jatiani, Shashi, Adolfo Aleman, Deepu Madduri, et al.. (2020). Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra. Clinical Lymphoma Myeloma & Leukemia. 20(9). 632–636.e1. 38 indexed citations
18.
Laganà, Alessandro, Sherry Bhalla, Adolfo Aleman, et al.. (2019). A Machine Learning Approach Identifies a 30-Gene Model That Predicts Sensitivity to Selinexor in Multiple Myeloma. Blood. 134(Supplement_1). 3101–3101. 3 indexed citations
19.
Hoang, Thanh T., Elizabeth Goldmuntz, Amy E. Roberts, et al.. (2018). The Congenital Heart Disease Genetic Network Study: Cohort description. PLoS ONE. 13(1). e0191319–e0191319. 65 indexed citations
20.
Chicas-Sett, Rodolfo, et al.. (2015). A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?. International Cancer Conference Journal. 5(2). 77–81. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiazhen Cui Breakdown of academic impact, for papers by Huiwen Jiang Breakdown of academic impact, for papers by Gurbakhash Kaur Breakdown of academic impact, for papers by Ruimin Hong Breakdown of academic impact, for papers by Kotaro Miyao Breakdown of academic impact, for papers by Satiro De Oliveira Breakdown of academic impact, for papers by Katherine D. Cummins Breakdown of academic impact, for papers by Shambavi Richard Breakdown of academic impact, for papers by Carrie Yuen Breakdown of academic impact, for papers by Chunrong Tong
Rankless by CCL
2026